Article Type
Changed
Fri, 01/18/2019 - 12:33
Display Headline
Subclinical hypothyroidism predicts cardiovascular mortality in NHANES

SAN FRANCISCO – Subclinical hypothyroidism is a strong independent predictor of cardiovascular mortality in a healthy population at baseline, a national study indicated.

Among 7,883 participants in the National Health and Nutrition Examination Survey III (NHANES III) who were over age 40 years and free of overt hyper- or hypothyroidism, 5.3% had subclinical hypothyroidism as defined by a thyroid-stimulating hormone level of 5-19.99 mIU/L and a thyroxine level of 5-12 mcg/dL. During a mean 12.3 years of follow-up, 25.2% of the subclinical hypothyroid group died of cardiovascular causes, compared with 16.9% of euthyroid controls, Dr. Tushar A. Tuliani reported at the annual meeting of the American College of Cardiology.

Similarly, death due specifically to ischemic heart disease occurred in 15.4% of the subjects with subclinical hypothyroidism, compared with 9.6% of euthyroid controls, added Dr. Tuliani of Wayne State University–Detroit Medical Center.

In a multivariate analysis that adjusted for standard cardiovascular risk factors and demographic variables, individuals with subclinical hypothyroidism had a 20% increased risk of all-cause mortality, a 24% increase in cardiovascular mortality, and a 34% increased risk of death from ischemic heart disease. All of these increases were statistically significant and clinically meaningful, he noted.

NHANES III is an in-depth weighted survey conducted by the Centers for Disease Control and Prevention in a nationally representative population.

Dr. Tuliani reported having no financial conflicts.

Meeting/Event
Author and Disclosure Information

Publications
Topics
Legacy Keywords
subclinical hypothyroidism, cardiovascular mortality, National Health and Nutrition Examination Survey III, NHANES III, Dr. Tushar A. Tuliani, American College of Cardiology
Sections
Author and Disclosure Information

Author and Disclosure Information

Meeting/Event
Meeting/Event

SAN FRANCISCO – Subclinical hypothyroidism is a strong independent predictor of cardiovascular mortality in a healthy population at baseline, a national study indicated.

Among 7,883 participants in the National Health and Nutrition Examination Survey III (NHANES III) who were over age 40 years and free of overt hyper- or hypothyroidism, 5.3% had subclinical hypothyroidism as defined by a thyroid-stimulating hormone level of 5-19.99 mIU/L and a thyroxine level of 5-12 mcg/dL. During a mean 12.3 years of follow-up, 25.2% of the subclinical hypothyroid group died of cardiovascular causes, compared with 16.9% of euthyroid controls, Dr. Tushar A. Tuliani reported at the annual meeting of the American College of Cardiology.

Similarly, death due specifically to ischemic heart disease occurred in 15.4% of the subjects with subclinical hypothyroidism, compared with 9.6% of euthyroid controls, added Dr. Tuliani of Wayne State University–Detroit Medical Center.

In a multivariate analysis that adjusted for standard cardiovascular risk factors and demographic variables, individuals with subclinical hypothyroidism had a 20% increased risk of all-cause mortality, a 24% increase in cardiovascular mortality, and a 34% increased risk of death from ischemic heart disease. All of these increases were statistically significant and clinically meaningful, he noted.

NHANES III is an in-depth weighted survey conducted by the Centers for Disease Control and Prevention in a nationally representative population.

Dr. Tuliani reported having no financial conflicts.

SAN FRANCISCO – Subclinical hypothyroidism is a strong independent predictor of cardiovascular mortality in a healthy population at baseline, a national study indicated.

Among 7,883 participants in the National Health and Nutrition Examination Survey III (NHANES III) who were over age 40 years and free of overt hyper- or hypothyroidism, 5.3% had subclinical hypothyroidism as defined by a thyroid-stimulating hormone level of 5-19.99 mIU/L and a thyroxine level of 5-12 mcg/dL. During a mean 12.3 years of follow-up, 25.2% of the subclinical hypothyroid group died of cardiovascular causes, compared with 16.9% of euthyroid controls, Dr. Tushar A. Tuliani reported at the annual meeting of the American College of Cardiology.

Similarly, death due specifically to ischemic heart disease occurred in 15.4% of the subjects with subclinical hypothyroidism, compared with 9.6% of euthyroid controls, added Dr. Tuliani of Wayne State University–Detroit Medical Center.

In a multivariate analysis that adjusted for standard cardiovascular risk factors and demographic variables, individuals with subclinical hypothyroidism had a 20% increased risk of all-cause mortality, a 24% increase in cardiovascular mortality, and a 34% increased risk of death from ischemic heart disease. All of these increases were statistically significant and clinically meaningful, he noted.

NHANES III is an in-depth weighted survey conducted by the Centers for Disease Control and Prevention in a nationally representative population.

Dr. Tuliani reported having no financial conflicts.

Publications
Publications
Topics
Article Type
Display Headline
Subclinical hypothyroidism predicts cardiovascular mortality in NHANES
Display Headline
Subclinical hypothyroidism predicts cardiovascular mortality in NHANES
Legacy Keywords
subclinical hypothyroidism, cardiovascular mortality, National Health and Nutrition Examination Survey III, NHANES III, Dr. Tushar A. Tuliani, American College of Cardiology
Legacy Keywords
subclinical hypothyroidism, cardiovascular mortality, National Health and Nutrition Examination Survey III, NHANES III, Dr. Tushar A. Tuliani, American College of Cardiology
Sections
Article Source

AT ACC 13

PURLs Copyright

Inside the Article

Vitals

Major finding: Healthy adults with subclinical hypothyroidism had a 24% greater risk of cardiovascular death than did euthyroid individuals during a mean 12.3 years of follow-up.

Data source: Analysis of 7,883 participants in the National Health and Nutrition Examination Survey III, a weighted, nationally representative sample.

Disclosures: NHANES III is sponsored by the Centers for Disease Control and Prevention. The presenter reported having no relevant financial interests.